Trial Profile
Clinical Trials Insight: 700038351
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2008
Price :
$35
*
At a glance
- Drugs CH 1504 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Chelsea Therapeutics
- 24 Oct 2008 New trial record.